Nutraceuticals and dietary supplements are FDA-regulated under DSHEA, with mandatory GMP compliance under 21 CFR Part 111. PMG's partner facilities are GMP-compliant, and our regulatory team understands the difference between a defensible structure-function claim and an FDA (Food and Drug Administration) Warning Letter waiting to happen.
Product Management Group makes private label and custom supplements, including capsules, tablets, powders and gummies, for brands in the US and Latin America. Private label stock supplements: from 1,000 units, varies by format — see individual product pages and usually launch in 60–90 days. Custom formulations are quoted per project, typically starting at 2,500–5,000 units depending on format.
Functional shots and liquid supplements, 2oz–33.8oz.
Everyday supplements in capsules or tablets.
Drink mixes, protein, creatine and collagen.
Single-serve sachets for drinks on the go.
Custom formulations are quoted per project, typically starting at 2,500–5,000 units depending on format.
Finished units: bottles, sachets, pouches or boxes, depending on format.
Every dosage format, every demanding active, every clean-label claim. We build supplements that pass identity testing, potency verification, and the consumer's read of the label.
21 CFR Part 111 requires rigorous identity testing, contaminant testing, and potency verification for every production run. Our facilities operate to this standard for every client, not just the ones who ask.
The line between a defensible structure-function claim and an impermissible disease claim is exactly where most supplement brands get into regulatory trouble. Our regulatory team reviews your draft claims against FDA guidance and case precedent before anything goes to print.
Gummies are technically demanding. Softgels require specialized equipment. Certain actives require coatings for stability or taste masking. We don't upsell format complexity; we tell you honestly what your product needs to perform as claimed.
Dietary supplements are regulated under DSHEA (1994) and the 2007 GMP Final Rule (21 CFR Part 111). Every supplement must have a New Dietary Ingredient notification if the ingredient wasn't marketed before October 15, 1994. Structure-function claims must be truthful, substantiated, and include the required disclaimer. The FTC also regulates advertising claims separately from FDA — meaning a claim that passes the label review can still draw an FTC enforcement action. Our regulatory team navigates both.
Stock supplement minimums: from 1,000 units, varies by format — see individual product pages. Capsules: 1,000 finished units; tablets: 5,000 finished units; stick packs: 3,000–10,000 finished units depending on fill (4g–12g per stick pack); stock powders: 1,000 finished units; stock gummies (60 count): 1,000 finished units; custom gummies (60 count): 2,500 finished units. Custom formulations are quoted per project, typically starting at 2,500–5,000 units depending on format.
A low MOQ is a cash-flow decision more than a manufacturing one. Producing 1,000 units costs more per unit than producing 10,000, because setup, testing, and documentation are largely fixed regardless of run size. What the smaller run buys is the ability to test a formula, a price, and a channel before committing capital to inventory you have not yet proven you can sell.
If your volumes are still uncertain, the practical path is a stock formula at the lowest minimum your format allows, then a custom program once repeat purchase data exists. We quote the format, the fill, and the packaging together so the per-unit number reflects the real project rather than a headline rate.
How the gel changes without sugar, allulose vs sugar alcohols vs monk fruit and stevia, what a sugar-free label needs, and realistic minimums.
Read the article →A phase-by-phase breakdown of R&D, ingredients, production, packaging, and compliance costs.
Read the article →Why minimums exist, what they cost below volume, and how to plan a first run you can sell through.
Read the article →Supplement brands live or die on trust — and trust starts with GMP-compliant manufacturing, defensible claims, and a partner who understands the regulatory landscape.
